State Ledger
Company profile

Amneal Pharmaceuticals, Inc. CIK 1723128

Ticker
AMRX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Bridgewater, NJ 08807
Fiscal year end
2025 (FY)
Market Data
Close
$19.91
Change
+$0.26
Change %
1.32%
Volume
72,389

AMRX · trading date Oct 9, 2026 · previous close $19.65 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$3.02B
Net income
$72.06M
Total assets
$3.68B
Total liabilities
—
Stockholders' equity
-$70.79M
Cash & equivalents
$282.03M
Operating income
$394.10M
Operating cash flow
$339.99M
Capital expenditures
$70.06M

Fiscal year 2025, via 10-K filed 2026-02-27. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
13.1%
Net margin
2.4%
Free cash flow
$269.93M
Free cash flow margin
8.9%
Liabilities / assets
—
Equity / assets
-1.9%
CapEx / revenue
2.3%
Operating cash flow / net income
4.72×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $3.02B $72.06M $3.68B — -$70.79M
2024 $2.79B -$116.89M $3.50B — -$109.27M
2023 $2.39B -$83.99M $3.47B — $19.78M
2022 $2.21B -$270.58M $3.80B — $298.42M
2021 $2.09B $13.16M $3.94B — $360.34M
Company Details
SIC code
2834
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-14
Financials filed via
Form 10-K
filed 2026-02-27

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Bridgewater, NJ 08807
400 CROSSING BOULEVARD
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:40 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New Jersey — Public Companies